Patient Registry Software

Global Market Trajectory & Analytics

MCP13881

EXECUTIVE ENGAGEMENTS

POOL

428
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

86
Interactions with Platform & by Email

PARTICIPANTS

17
Unique # Participated

VALIDATIONS

7
Responses Validated*

COMPANIES

42
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

111

PAGES

183

EDITION

6

PRICE

USD 4950

CODE

MCP13881


COMPETITIVE METRICS

COMPANY

D S N T

% *

Dacima Software, Inc.

Debra of America

Duke Clinical Research institute

Evado Pty. Ltd.

FIGmd, Inc.

Global Vision Technologies, Inc.

Ifa Systems AG

Imagetrend, Inc.

M2S, Inc.

McKesson Corporation

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Patient Registry Software estimated at US$990 Million in the year 2020, is projected to reach a revised size of US$2.1 Billion by 2027, growing at a CAGR of 11.3% over the analysis period 2020-2027. Product Registries, one of the segments analyzed in the report, is projected to record a 10.6% CAGR and reach US$565.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Health Service Registries segment is readjusted to a revised 10.8% CAGR for the next 7-year period.
The Patient Registry Software market in the U.S. is estimated at US$291.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$368.4 Million by the year 2027 trailing a CAGR of 10.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.9% and 9.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.
In the global Disease Registries segment, USA, Canada, Japan, China and Europe will drive the 11.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$433.1 Million in the year 2020 will reach a projected size of US$937.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$248 Million by the year 2027.

SELECT PLAYERS

Dacima Software, Inc.; Evado Pty. Ltd.; FIGmd, Inc.; Global Vision Technologies, Inc.; Ifa Systems AG; Imagetrend, Inc.; Liaison Technologies; M2S, Inc.; McKesson Corporation; Optum, Inc.; Velos, Inc.

SEGMENTS

» End-Use (Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs, Other End-Uses) » Registry Type (Product Registries, Health Service Registries, Disease Registries)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Patient Registry Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Patient Registry Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Patient Registry Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
World Current & Future Analysis for Product Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Product Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Product Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Health Service Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Health Service Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Health Service Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Disease Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Disease Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Disease Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Hospitals & Medical Practices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Hospitals & Medical Practices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Hospitals & Medical Practices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Pharma, Biotech & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Pharma, Biotech & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Pharma, Biotech & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Government Organizations & TPAs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Government Organizations & TPAs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Government Organizations & TPAs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
UNITED STATES
USA Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
USA Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
USA 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
USA Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
USA Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
USA 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
CANADA
Canada Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Canada Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Canada 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
Canada Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Canada Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Canada 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
JAPAN
Japan Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Japan Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Japan 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
Japan Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Japan Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Japan 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
CHINA
China Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
China Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
China 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
China Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
China Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
China 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
EUROPE
Europe Current & Future Analysis for Patient Registry Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
Europe Historic Review for Patient Registry Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Europe 15-Year Perspective for Patient Registry Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027
Europe Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Europe Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Europe 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
Europe Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Europe Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Europe 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
FRANCE
France Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
France Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
France 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
France Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
France Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
France 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
GERMANY
Germany Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Germany Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Germany 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
Germany Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Germany Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Germany 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
ITALY
Italy Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Italy Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Italy 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
Italy Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Italy Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Italy 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
UK Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
UK 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
UK Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
UK Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
UK 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Rest of Europe Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Rest of Europe 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
Rest of Europe Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Rest of Europe Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Rest of Europe 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Asia-Pacific Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Asia-Pacific 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
Asia-Pacific Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Asia-Pacific Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Asia-Pacific 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Rest of World Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Rest of World 15-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2012, 2018 & 2027
Rest of World Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Rest of World Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Rest of World 15-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2012, 2018 & 2027
Total Companies Profiled: 42

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com